The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

At the recent CURE Educated Patient® Lung Cancer Summit, held in tandem with the 2025 PER® New York Lung Cancer Symposium, Dr ...

Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.

The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).

Treatment innovations in advanced lung cancer and melanoma over the past 2 decades have significantly improved OS, but they ...

Living with lung cancer often means spending more time in waiting rooms than in the moments that matter, but a new South ...

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...

Lung cancer is the leading cause of cancer-related deaths in the United States. As we start Lung Cancer Awareness Month, a new report shows where we stand on fighting against the disease, including ...

This summer, 75-year-old Antioch Township Treasurer and Mesick resident Kathy Soerries was preparing for a family vacation to ...

Approximately 20% of new lung cancer diagnoses occur in nonsmokers in the U.S., according to The Ohio State University ...

Joanne Cure, 78, survived stage 4 lung cancer after being given two years to live, crediting her faith, determination, and ...